For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.

Healthcare Costs of Post-Prostate Biopsy Sepsis.

TitleHealthcare Costs of Post-Prostate Biopsy Sepsis.
Publication TypeJournal Article
Year of Publication2019
AuthorsGross MD, Alshak MN, Shoag JE, Laviana AA, Gorin MA, Sedrakyan A, Hu JC
JournalUrology
Date Published2019 Jun 21
ISSN1527-9995
Abstract

Sepsis following transrectal prostate biopsy occurs in 2%-5% of cases and the risk is increasing. We performed a comprehensive literature search for the cost of post-prostate biopsy sepsis to define the potential cost savings of reducing infectious complications. Reporting of cost is varied and presents a challenge to interpretation. Length of hospitalization ranged from 1.1 to 14 days and the percent admitted to an ICU ranged from 1.1% to 25%. The estimated cost of sepsis post-prostate biopsy, adjusted for inflation, ranged from $8,672 to $19,100. Healthcare costs of treating post-biopsy infection are substantial. Our findings should guide payers and policymakers, especially in value-based care models.

DOI10.1016/j.urology.2019.06.011
Alternate JournalUrology
PubMed ID31229516
Division: 
Comparative Effectiveness & Outcomes Research
Category: 
Faculty Publication